Clinical Research Directory
Browse clinical research sites, groups, and studies.
EndeavorOTC™ Prospective Product Registry
Sponsor: Akili Interactive Labs, Inc.
Summary
The EndeavorOTC product registry aims to collect real world data from EndeavorOTC users. The objectives of this registry are to describe clinical and demographic characteristics, treatment patterns, clinical and quality of life outcomes, and healthcare utilization in EndeavorOTC users in a real-world setting.
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
198
Start Date
2023-10-03
Completion Date
2026-12-31
Last Updated
2024-06-27
Healthy Volunteers
Not specified
Conditions
Interventions
EndeavorOTC
EndeavorOTC™ is an over-the-counter digital therapeutic designed to improve attention function, ADHD symptoms, and quality of life in users 18 years of age and older with primarily inattentive or combined-type ADHD, who have been identified as having a significant attentional impairment. EndeavorOTC utilizes the same proprietary technology underlying EndeavorRx, a prescription digital therapeutic indicated to improve attention function in children ages 8-12. EndeavorOTC is not intended to be a replacement for any form of ongoing treatment. EndeavorOTC is deployed on mobile devices and incorporates adaptive, simultaneous cognitive tasks in a consumer-grade action videogame-based platform with high-quality graphics and reward mechanisms.
Locations (1)
Akili Interactive Labs, Inc.
Boston, Massachusetts, United States